Company Filing History:
1 out of 1,310 
1 out of 816 
1 out of 5 Years Active: 2012
Title: Mie Hata: Innovator in G-Protein-Conjugated Receptor Agonists
Introduction
Mie Hata is a prominent inventor based in Kyoto, Japan. She has made significant contributions to the field of biochemistry, particularly in the development of compounds that target G-protein-coupled receptors. Her innovative work has implications for various therapeutic applications, including appetite regulation and metabolic disorders.
Latest Patents
Mie Hata holds a patent for a novel aralkyl carboxylic acid compound that acts as a G-protein-conjugated receptor agonist. This compound exhibits agonistic activity on GPR-120 and/or GPR-40, making it useful as an appetite regulator, an anti-obesity agent, and a therapeutic agent for diabetes, among other conditions. The compound is represented by a specific general formula, which includes various structural components that enhance its efficacy.
Career Highlights
Throughout her career, Mie Hata has worked with esteemed institutions such as the Japan Science and Technology Agency and Kyoto University. Her research has focused on the development of innovative therapeutic agents that address significant health challenges.
Collaborations
Mie Hata has collaborated with notable colleagues, including Gozoh Tsujimoto and Akira Hirasawa. These partnerships have contributed to her success in advancing research in her field.
Conclusion
Mie Hata's contributions to the field of biochemistry and her innovative patent for G-protein-conjugated receptor agonists highlight her role as a leading inventor. Her work continues to pave the way for new therapeutic solutions in healthcare.